Remote Observed Therapy

Not Applicable

• Conditions: HIV/AIDS; Tuberculosis

• Registration Number: PACTR201806003352147
• Lead Sponsor: igerian Institute of Medical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-27
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

(a) Confirmed TB patients of not less than 15 years of age, receiving a regimen containing only oral medications, completed at least two weeks of DOT. (b) Demonstrate proficiency in using a smart phone after 1 or 2 training sessions. (c) Accurately identify each medication and self -administered by mouth. (d) Communicate in English or in a language spoken by available observers. (e) Have access to a private area that support patient confidentiality in the observation environmen

Exclusion Criteria

(a) Patients with current or prior diagnosis of multidrug resistant (MDR) - TB or a severe mental illness. (b) Patients with disabilities that prevent full participation e.g. vision or hearing impaired. (c) Patients who experience adverse reaction(s) to prescribed medication (d) Patients with low adherence rate on DOT. (e) Patients at risk for hepatic complications. (f) Pediatric patients and (g) Homeless patients.

Study & Design

• Study Type: Interventional
• Study Design: Not specified